Business Context and Reporting Period
This Form 8-K was filed by Harvard Bioscience, Inc. on March 16, 2016. The report addresses a regulatory compliance issue regarding the company's listing status on the NASDAQ Stock Market.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on a listing delisting notice and the reasons for a delayed financial report.
Material Changes and Events
- NASDAQ Non-Compliance: The company received a Staff Determination Notice from NASDAQ stating it is not in compliance with Listing Rule 5250(c)(1) due to the failure to timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2015.
- Forensic Investigation: The delay in filing the Form 10-K is attributed to a forensic investigation initiated after preliminary findings indicated that an employee at Denville Scientific, Inc. (a wholly-owned subsidiary) embezzled funds and manipulated records to conceal the theft.
- Regulatory Filing: On March 14, 2016, the company filed a Notification of Late Filing on Form 12b-25.
Outlook, Risks, and Management Commentary
- Compliance Plan: The company has until May 16, 2016, to submit a plan of compliance to NASDAQ.
- Expected Resolution: Management expects to file the Form 10-K by May 16, 2016, which would cure the listing failure and eliminate the need for a separate compliance plan.
- Trading Status: The company expects its common stock to continue to be listed and traded on NASDAQ during this process.
- Risks: The primary risk identified is the potential delisting if the Form 10-K is not filed by the deadline, alongside the financial and operational impact of the embezzlement and record manipulation.
Investor Verification Checklist
- Verify the final filing date of the Form 10-K for the fiscal year ended December 31, 2015.
- Monitor the outcome of the forensic investigation regarding the Denville Scientific, Inc. employee.
- Confirm the company's continued listing status on NASDAQ past the May 16, 2016 deadline.
- Review the upcoming Form 10-K for restated financial figures related to the embezzlement.